Hyperfine Inc. Class A Common Stock (HYPR)

FairStock Score: 57/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Hyperfine sells a portable MRI system, the Swoop, for intensive care, neurology, and emergency settings. The product idea is useful, and revenue is moving: in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $3.9M versus $2.7M in fiscal Q2 2025, the quarter ended 2025-06-30. For fiscal year 2025, the year ended 2025-12-31, revenue was $13.6M, up from $12.9M in fiscal year 2024, the year ended 2024-12-31, and $11.0M in fiscal year 2023, the year ended 2023-12-31. But growth has not created a self-sustaining business. Fiscal year 2025 net income was -$35.6M, fiscal year 2024 was -$40.7M, and fiscal year 2023 was -$44.2M. In fiscal Q2 2026, net income was -$9.3M on $3.9M of revenue. Trailing free cash flow is -$27.5M, a -32.4% FCF yield on the $85.0M market cap at the 2026-10-13 close. FairStock's calculations show P/E -2.30, P/B 2.43, ROE -96.97%, ROCE -38.82%, Piotroski 4/9, and Altman Z-Score -5.22. That is not a Graham bargain; it is a cash-burning enterprise that likely needs capital. The provided D/E of 0.36 is not alarming by itself, but negative cash flow and a -5.22 Altman score are warning signs. Does portable MRI create a moat? The technology may have barriers, yet the financial statements show no durable returns, no pricing power evidence, and no profits. At 2.43 times book, the price is a bet on future adoption. I prefer proven earning power and a margin of safety; until losses shrink and cash flow turns, this remains speculative.

In plain English: Hyperfine makes a portable MRI machine called Swoop for hospitals. Sales are growing, but the company still loses a lot of money and burns cash, so the business looks weak on profits and cash flow. At $0.85 a share, there are no earnings to make it look cheap, so it is a speculative situation rather than a proven bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer